Skip to main content
OpenTrials

Clinical trial condition

Breast Cancer

Explore clinical trials studying Breast Cancer. Study availability and eligibility vary by location and protocol.

6,475 public trials 1,149 recruiting studies
Refine in advanced search Browse all conditions

Breast Cancer trial results

Completed

Study of XL147 (SAR245408) or XL765 (SAR245409) in Combination With Letrozole in Subjects With Breast Cancer

NCT01082068

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Investigational Site Number 1537 Los Angeles, California, United States
  • Investigational Site Number 1601 Denver, Colorado, United States
  • Investigational Site Number 1238 Fort Meyers, Florida, United States
  • Investigational Site Number 1441 Chicago, Illinois, United States
View all 17 locations
View Trial Details
Completed

Study of XL147 (SAR245408) in Combination With Trastuzumab or Paclitaxel and Trastuzumab in Subjects With Metastatic Breast Cancer Who Have Progressed on a Previous Trastuzumab-based Regimen

NCT01042925

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Investigational Site Number 1537 Los Angeles, California, United States
  • Investigational Site Number 1238 Fort Meyers, Florida, United States
  • Investigational Site Number 1138 Boston, Massachusetts, United States
  • Investigational Site Number 1330 Detroit, Michigan, United States
View Trial Details
Completed

Docetaxel Plus Imatinib Mesylate in Metastatic Breast Cancer

NCT00193180

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Northeast Georgia Medical Center Gainesville, Georgia, United States
  • Consultants in Blood Disorders and Cancer Louisville, Kentucky, United States
  • Baton Rouge General Medical Center Baton Rouge, Louisiana, United States
  • Methodist Cancer Center Omaha, Nebraska, United States
View Trial Details
Completed

Rucaparib(CO-338;Formally Called AG-014699 or PF-0136738) in Treating Patients With Locally Advanced or Metastatic Breast Cancer or Advanced Ovarian Cancer

NCT00664781

Conditions
Adnexal Diseases, BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, +24 more
Locations
  • Queen Elizabeth Hospital at University Hospital of Birmingham NHS Trust Birmingham, England, United Kingdom
  • Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom
  • Cancer Research UK and University College London Cancer Trials Centre London, England, United Kingdom
  • Christie Hospital Manchester, England, United Kingdom
View Trial Details

Related conditions